Experience

Prellis Biologics

• United States
• Biotechnology
• 1 - 100 Employee

• Vice President & Head of Business Development

  • Nov 2022 - Present

• Vice President of Business Development

  • Jan 2022 - Nov 2022



Sutro Biopharma, Inc.

• United States
• Biotechnology Research
• 100 - 200 Employee

• Senior Director - Business Operations & Strategy

  • Oct 2017 - Jan 2022

  Managing both Business Development, and Operational Improvement efforts to further value creation through several distinct avenues. In particular, I am identifying and lining up business opportunities and partnerships around Sutro's core technology platform, as well as our drug discovery pipeline. Managing the entire deal lifecycle from initial outreach, through deal execution, to post deal support.

• Senior Director - Protein Biochemistry

  • Jul 2015 - Oct 2017

  In charge of the Protein Biochemistry Group. Overseeing expression, purification and characterization of drug leads for a variety of testing - ranging from early stage cell-biology to pre-clinical in vivo models. Responsible for process transfer to the development team. Project leader for partnered and in-house projects. Also responsible for technology development in cell-free expression, nnAA incorporation and site specific protein conjugation.

• Director - Protein Biochemistry

  • Mar 2014 - Jul 2015

  In charge of the Protein Biochemistry Group. Overseeing expression, purification and characterization of drug leads for a variety of testing - ranging from early stage cell-biology to pre-clinical in vivo models. Responsible for process transfer to the development team. Project leader for partnered and in-house projects. Also responsible for technology development in cell-free expression, nnAA incorporation and site specific protein conjugation.

• Associate Director - Protein Biochemistry

  • Nov 2012 - Mar 2014

  In charge of the Protein Biochemistry Group. Overseeing expression, purification and characterization of drug leads for a variety of testing - ranging from early stage cell-biology to pre-clinical in vivo models. Responsible for process transfer to the development team. Project leader of a drug discovery collaboration with Pfizer for novel, peptide-based therapeutics. Responsible for multiple POC partner projects and in-house technology platform projects, including cell-free and nnAA… Show more In charge of the Protein Biochemistry Group. Overseeing expression, purification and characterization of drug leads for a variety of testing - ranging from early stage cell-biology to pre-clinical in vivo models. Responsible for process transfer to the development team. Project leader of a drug discovery collaboration with Pfizer for novel, peptide-based therapeutics. Responsible for multiple POC partner projects and in-house technology platform projects, including cell-free and nnAA incorporation technology development.

• Associate Director - Protein Science

  • Mar 2012 - Nov 2012

  In charge of downstream development efforts, ranging from developing recovery processes for bio-pharmaceutical production to implementing analytical strategies for process monitoring. Project leader of a drug discovery collaboration with an outside partner. Group leader of the purification group, supporting projects from early stage research to process scale-up.

• Group Leader - Protein Purification

  • May 2011 - Mar 2012

  In charge of downstream development efforts, ranging from developing recovery processes for bio-pharmaceutical production to implementing analytical strategies for process monitoring. Actively involved in outside collaborations on the process development side.

• Process Development Engineer

  • Aug 2008 - May 2011



Delos Insurance

• Insurance
• 1 - 100 Employee

• Analyst Intern

  • Jun 2007 - Aug 2007

  Sole implementer of a new dynamic financial model to better the understanding of risk factors and financial returns. Successfully programmed and populated the model during a short three months. At the end of my internship I was superseded by a full-time employee to take over maintenance of the model. I effectively created a new position as I added a new key tool to the comapny's understanding of financial risks. Sole implementer of a new dynamic financial model to better the understanding of risk factors and financial returns. Successfully programmed and populated the model during a short three months. At the end of my internship I was superseded by a full-time employee to take over maintenance of the model. I effectively created a new position as I added a new key tool to the comapny's understanding of financial risks.